Therapeutic effect of ketogenic diet therapy combined with eslicarbazepine acetate on patients with drug refractory epilepsy

Xu Jun; Wang Liping; Lyu Xianhe; Chen Yanan

您当前的位置：

首页 >

文章列表页 >

Therapeutic effect of ketogenic diet therapy combined with eslicarbazepine acetate on patients with drug refractory epilepsy

更新时间：2022-11-04

- Therapeutic effect of ketogenic diet therapy combined with eslicarbazepine acetate on patients with drug refractory epilepsy
- Health Medicine Research and Practice Vol. 19, Issue 2, Pages: 18-22(2022)
- 作者机构：
  
  郑州大学人民医院/河南省人民医院神经内科
- 作者简介：
- 基金信息：
- DOI：
  CLC： R742.1
- Published：2022，
扫描看全文
Xu Jun, Wang Liping, Lyu Xianhe, et al. Therapeutic effect of ketogenic diet therapy combined with eslicarbazepine acetate on patients with drug refractory epilepsy. [J]. Health Medicine Research and Practice 19(2):18-22(2022)
DOI：

Xu Jun, Wang Liping, Lyu Xianhe, et al. Therapeutic effect of ketogenic diet therapy combined with eslicarbazepine acetate on patients with drug refractory epilepsy. [J]. Health Medicine Research and Practice 19(2):18-22(2022) DOI：

摘要

目的探讨生酮饮食疗法对药物难治性癫痫患者癫痫发作情况、免疫功能及神经递质水平的影响。方法选取2019年12月—2020年12月河南省某医院收治的89例药物难治性癫痫患者为研究对象。采用随机数字表法

将患者分为观察组（n=45）与对照组（n=44）。对照组患者采用醋酸艾司利卡西平进行治疗。观察组在对照组基础上增加生酮饮食治疗。比较2组患者治疗效果。比较2组患者治疗前1天、治疗6个月时T淋巴细胞总值（CD3

）和T淋巴细胞亚群（CD4

、CD8

）、免疫球蛋白A（IgA）、免疫球蛋白M（IgM）、免疫球蛋白G（IgG）水平。比较2组患者治疗前1天、治疗6个月时去甲肾上腺素（NE）、多巴胺（DA）、5-羟色胺（5-HT）水平。比较2组患者治疗期间的不良反应发生情况。结果观察组患者治疗有效率为66.67%

高于对照组的45.45%

差异有统计学意义（P

0.05）。治疗6个月时

2组患者IgA、IgG及IgM水平均低于治疗前1天

且观察组低于对照组

差异均有统计学意义（P

0.05）。治疗6个月时

2组患者CD3

、CD4

水平均高于治疗前1天

且观察组高于对照组

差异有统计学意义（P

0.05）。治疗6个月时

2组患者CD8

水平均低于治疗前1天

且观察组低于对照组

差异有统计学意义（P

0.05）。治疗6个月时

观察组患者NE、DA、5-HT水平均高于治疗前1天

且观察组高于对照组

差异均有统计学意义（P

0.05）。2组患者不良反应发生率比较

差异无统计学意义（P

0.05）。结论生酮饮食疗法联合醋酸艾司利卡西平对药物难治性癫痫具有显著的干预效果

可以通过改善患者神经递质水平

有效控制癫痫发作及减少对免疫功能的损坏

且具有较高的安全性

临床可以推广使用。

Abstract

Objective To investigate the effects of ketogenic diet therapy on status epilepticus

immune function and neurotransmitter levels in patients with drug refractory epilepsy. Methods A total of 89 patients with drug refractory epilepsy treated in a hospital in Henan Province from December 2019 to December 2020 were selected as the objects. The patients were randomly divided into observation group（n=45） and control group（n=44）. The patients in the control group were treated with eslicarbazepine acetate. The observation group was treated with ketogenic diet on the basis of the control group. The therapeutic effects of the two groups were compared. The levels of leukocyte differentiation antigen 3（CD3

）

leukocyte differentiation antigen 8（CD8

）

leukocyte differentiation antigen 4（CD4

）

immunoglobulin A（IgA）

immunoglobulin M（IgM） and immunoglobulin G（IgG） were compared between the two groups 1 day before treatment and 6 months after treatment. The levels of norepinephrine（NE）

dopamine（DA） and 5-hydroxytryptamine（5-HT） were compared between the two groups 1 day before treatment and 6 months after treatment. The adverse reactions were compared between the two groups during treatment. Results The effective rate of patients in the observation group was 66.67%

which was higher than that in the control group（45.45%）

and the difference was statistically significant（P

0.05）. At 6 months after treatment

the levels of IgA

IgG and IgM in the two groups were lower than those in the first day before treatment

those in the observation group were lower than those in the control group

and the difference was statistically significant（P

0.05）. At 6 months after treatment

the levels of CD3

and CD4

in the two groups were higher than those in the first day before treatment

those in the observation group were significantly higher than those in the control group

and the difference was statistically significant（P

0.05）. At 6 months after treatment

the level of CD8

in the two groups was lower than that in the first day before treatment

the level in the observation group was lower than that in the control group

and the difference was statistically significant（P

0.05）. At 6 months after treatment

the levels of NE

DA and 5-HT in the observation group were higher than those in the first day before treatment

the levels in the observation group were significantly higher than those in the control group

the difference was statistically significant（P

0.05）. There was no significant difference in the incidence of adverse reactions between the two groups（P

0.05）. Conclusion Ketogenic diet therapy combined with eslicarbazepine acetate has a significant intervention effect on drug refractory epilepsy. It can effectively control seizures and reduce the damage to immune function by improving the level of neurotransmitters in patients with drug refractory epilepsy. It has high safety and can be widely used in clinic.

关键词

生酮饮食药物难治性癫痫免疫功能神经递质水平不良反应

Keywords

Ketogenic dietDrug refractory epilepsyImmune functionNeurotransmitter levelAdverse reaction

references

查看原文

Views

108

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effect of Xuebijing injection combined with somatostatin on inflammatory factors and adverse reactions in patients with acute pancreatitis

Clinical observation of intermittent hemodialysis in combination with ulinastatin in the treatment of sepsis patients with acute kidney injury

Influence of autologous blood transfusion technology on coagulation function, inflammatory factors and immune function in patients undergoing hip replacement under general anesthesia

Effect observation of Bailing capsule in combination with candesartan in the treatment of diabetic glomerulosclerosis

Analysis of serum 25-hydroxyvitamin D₃ and immunoglobulin expression levels in children with recurrent respiratory tract infections

Related Author

Zhang Shupei

Zhang Li

Cui Xiaoyong

Liang Caige

Ma Dongdong

Zheng Chenchen

Shu Ping

Zhou Liang

Related Institution

Emergency Department, Luohe Sixth People’s Hospital

Neurology Department, Luohe Sixth People’s Hospital

Emergency Medicine Dept., the First Affiliated Hospital of Henan University of Science and Technology

Department of Anesthesiology, Jiangyou Second People’s Hospital

Department of Orthopedics, Jiangyou Second People’s Hospital

⁰